Andrew Belch

Independent Researcher

Publications

723

Citations

H-Index

i10-Index

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

14 total

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial PDF

Thierry Façon, Meletios Α. Dimopoulos, Nathalie Meuleman, Andrew Belch, Mohamad Mohty et al. - Leukemia, 2019

Cited by 224 OpenAlex

Flavopiridol in Untreated or Relapsed Mantle-Cell Lymphoma: Results of a Phase II Study of the National Cancer Institute of Canada Clinical Trials Group

C. Tom Kouroukis, Andrew Belch, Michael Crump, Elizabeth A. Eisenhauer, Randy D. Gascoyne et al. - Journal of Clinical Oncology, 2003

Cited by 281 OpenAlex

Research Topics

Lymphoma Diagnosis and Treatment (4) Multiple Myeloma Research and Treatments (4) Monoclonal and Polyclonal Antibodies Research (3) Sarcoma Diagnosis and Treatment (2) Acute Myeloid Leukemia Research (2)

Affiliations

University of Alberta

CA 2008 - 1980

National Cancer Centre Japan

JP 2003 - 2003

University of Bologna

IT 2006 - 2006

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers

Andrew Belch

Publication & Citation Trends

Publications

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial PDF

Flavopiridol in Untreated or Relapsed Mantle-Cell Lymphoma: Results of a Phase II Study of the National Cancer Institute of Canada Clinical Trials Group

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back